Biosceptre International Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Biosceptre International Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10659
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Its diagnostic products are used for the detection of various cancer tissues, and treatment of various cancers in humans and other mammals. Biosceptre offers clinical product development programs such as polyclonal antibody, domain antibodies and topical formulation to treat basal cell carcinoma and other skin cancers. The company also develops diagnostics and a line of veterinary therapeutic products. It has operations in the UK, Australia, and the US. Biosceptre is headquartered in Cambridge, the UK.

Biosceptre International Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biosceptre International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biosceptre International Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Biosceptre International Raises USD10.7 Million in Series A Financing 11
Biosceptre International Raises USD0.2 Million in Venture Financing 12
Biosceptre Raises Funds through Venture Financing 13
Biosceptre Raises USD0.7 Million in Venture Financing 14
Biosceptre International Raises USD4.7 Million in Venture Financing 15
Partnerships 16
AIBN Enters Into Co-Development Agreement With Biosceptre For Cancer Antibodies 16
Biosceptre International Ltd – Key Competitors 17
Biosceptre International Ltd – Key Employees 18
Biosceptre International Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biosceptre International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biosceptre International Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Biosceptre International Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biosceptre International Raises USD10.7 Million in Series A Financing 11
Biosceptre International Raises USD0.2 Million in Venture Financing 12
Biosceptre Raises Funds through Venture Financing 13
Biosceptre Raises USD0.7 Million in Venture Financing 14
Biosceptre International Raises USD4.7 Million in Venture Financing 15
AIBN Enters Into Co-Development Agreement With Biosceptre For Cancer Antibodies 16
Biosceptre International Ltd, Key Competitors 17
Biosceptre International Ltd, Key Employees 18
Biosceptre International Ltd, Subsidiaries 19

List of Figures
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biosceptre International Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Biosceptre International Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Datalogic SpA (DAL):企業の財務・戦略的SWOT分析
    Datalogic SpA (DAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Velvet Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Velvet Energy Ltd (Velvet Energy) is an oil and gas exploration company that explores and develops oil and liquid-rich natural gas from its assets. The company’s exploration and development operation assets are located in Deep Basin in West-Central Alberta. It produces 17,000 barrels of oil …
  • Merrimack Pharmaceuticals Inc (MACK):医療機器:M&Aディール及び事業提携情報
    Summary Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes medicines for the treatment of various types of cancers. The company’s marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (mark …
  • MAMEE-Double Decker (M) Sdn Bhd:企業の戦略的SWOT分析
    MAMEE-Double Decker (M) Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Anthelio Healthcare Solutions Inc.-医療機器分野:企業M&A・提携分析
    Summary Anthelio Healthcare Solutions Inc. (Anthelio), formerly PHNS Inc., is a healthcare IT service company that offers information technology and business process services to hospitals, physician practice groups and other healthcare providers. The company’s suite of software solutions include int …
  • PTC KAMAZ:企業のM&A・事業提携・投資動向
    PTC KAMAZ - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PTC KAMAZ Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • The Hub Power Co Ltd (HUBC):企業の財務・戦略的SWOT分析
    The Hub Power Co Ltd (HUBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Broadcom Inc (AVGO):企業の財務・戦略的SWOT分析
    Broadcom Inc (AVGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Stantec Inc (STN)-石油・ガス分野:企業M&A・提携分析
    Summary Stantec Inc. (Stantec) is a consulting services company offering architectural, engineering, and environmental services. Its service portfolio includes architecture and interior design, building engineering, community design services, geomatics, geotechnical engineering, landscape architectu …
  • Summit Exploration and Production Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Summit Exploration and Production Ltd (Summit), a subsidiary of Sumitomo Corp, is an independent upstream oil and gas company that explores, develops and produces oil and gas assets. The company holds operator interests for exploration in the UK North Sea. It has two production assets such a …
  • Brunei LNG Sdn Bhd:企業の戦略的SWOT分析
    Brunei LNG Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Albertsons Companies, Inc.:戦略・SWOT・企業財務分析
    Albertsons Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Albertsons Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Rajesh Exports Limited:企業の戦略・SWOT・財務情報
    Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report Summary Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Advanced Energy Industries Inc (AEIS):電力:M&Aディール及び事業提携情報
    Summary Advanced Energy Industries, Inc. (Advanced Energy) is a provider of power conversion, measurement and control solutions. The company designs, manufactures, sells, and supports power conversion products and solutions. These products are used in various applications ranging from manufacturing …
  • PriceSmart, Inc.:企業の戦略・SWOT・財務情報
    PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report Summary PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Luye Pharma Group Co Ltd (2186):製薬・医療:M&Aディール及び事業提携情報
    Summary Luye Pharma Group Co Ltd (Luye Pharma) is a pharmaceutical company that develops, produces and markets pharmaceutical products in the therapeutic areas of oncology, cardiovascular, metabolism and central nervous system. The company’s products include sodium aescinate for injection, xuezhikan …
  • Marriott International Inc:企業のM&A・事業提携・投資動向
    Marriott International Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Marriott International Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • NanoRepro AG (NN6):製薬・医療:M&Aディール及び事業提携情報
    Summary NanoRepro AG (NanoRepro) is a manufacturer of fast-diagnostics and nutritional food supplements for home and clinical use. The company offers wide range of rapid diagnostic tests products in the areas of family planning, disease detection (preventive healthcare), food intolerances, allergies …
  • Trane Inc:企業の戦略的SWOT分析
    Trane Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • ConMed Corp (CNMD):企業の財務・戦略的SWOT分析
    ConMed Corp (CNMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆